Introduction
Infection in the neonate presents a diagnostic dilemma as the clinical presentation is non-speci®c and there is no single reliable test for the early con®rmation of de®nite sepsis. Culture of body¯uids, particularly blood and cerebrospinal¯uid, are regarded as the gold standard for the diagnosis of infection but ®nal culture results are usually not available until at least 48±72 h after collection. This results in the over treatment of large numbers of neonates who present with clinical suspicion of sepsis. This is of particular relevance in a developing country such as South Africa with limited health resources; treatment of neonates for suspected sepsis results in increased costs due to expensive intravenous antibiotics and prolonged hospital stay. Early con®rma-tion of de®nite infection would have a signi®cant impact on reducing healthcare costs by allowing shorter duration of treatment and hospitalization. It would also free up sorely needed hospital beds for those neonates who really require hospital admission.
C reactive protein (CRP) is an acute phase reactant, which has been used in the diagnosis of bacterial infection in the neonate. 1 Interleukin 6 (IL6) is a proin¯ammatory cytokine produced by monocytes and macrophages activated by bacterial infection. 2 It is a hepatocyte stimulating factor, which gives rise to the acute phase response, leukocytosis and an increase in immature neutrophils. 3 It has a relatively short half-life and levels peak rapidly before decreasing.
2 CRP is secondarily synthesized by the liver, mainly under the stimulus of IL6. 4 Previous studies have shown IL6 to be a useful marker of early infection in the neonate.
5;6 The combination of IL6 and CRP appears to provide the most reliable indication of early neonatal sepsis. 4;7;8 The purpose of this study was to evaluate serial measurements of IL6 in the early diagnosis of neonatal infection in our patient population.
Subjects and Methods
The study was conducted in the neonatal unit of the Johannesburg Hospital between February and May 1998. Subjects included all neonates who were investigated for suspected sepsis. Clinical signs suggestive of infection included respiratory distress, episodes of apnoea and/or bradycardia, lethargy, irritability, seizures, temperature instability, increasing ventilatory requirements, hypotension, poor peripheral circulation, abdominal distention and feeding intolerance. Babies presenting with the aforementioned signs during the ®rst 7 days after birth were routinely treated with penicillin G 200 000 U/kg/ day and amikacin 15 mg/kg/day intravenously. A small number of infants were evaluated for sepsis due to an offensive smell, maternal chorioamnionitis or prolonged rupture of membranes. These infants did not routinely receive antibiotic therapy. Neonates who developed signs or symptoms of sepsis after 7 days of age were regarded as potentially having nosocomially acquired infection and were treated with antibiotics according to the unit protocol at the time. Initial blood specimens included full blood count (FBC), (including differential white cell count and platelet count), CRP, blood cultures, and IL6 (referred to as CRP1 and IL61). Full blood count, IL6, and CRP measurements were repeated after 24 h (referred to as CRP2 and IL62).
The C reactive protein. Samples for CRP analysis were spun down immediately after collection and taken to the emergency laboratory where they were processed within 2 h of collection. The CRP was measured on the Beckman Synchron CXÒ system CX7, using a turbidometric method. CRP combines with a speci®c antibody to form insoluble antigen±antibody complexes and the change in absorbance at 340 nm over time is used to calculate the CRP concentration. The cost of the CRP assay is approximately $2.
Blood culture and FBC. Blood specimens were sent for culture in Paediatric FAN bottles containing charcoal and were analysed using a non-radiometric Bacti-Alert system in the microbiology laboratory. Samples for FBC, differential and platelets were taken in EDTA tubes and analysed on the Technicon H3 TRC/RTX TM system, Bayer instrumentation in the haematology laboratory.
Ethical issues
The Committee for Research on Human Subjects of the University of the Witwatersrand approved the study. Written informed consent was obtained from the parents or guardian prior to enrollment of the babies. Where required, information regarding the study was provided in the parent's home language.
Results

Demographic characteristics
Two hundred and seventy-eight neonates were eligible for the study. Nineteen were excluded for reasons related to problems with specimens, including insuf®cient blood samples, specimens becoming mislaid or insuf®cient data for analysis. A further four neonates were excluded due to parental refusal. There were thus 255 infants included in the ®nal analysis, 46. The number of neonates in the various categories of infection is shown in Table 1 .
Study categories 1±6 were comparable at baseline for the following variables: sex, antenatal care, mode of delivery, RPR positivity, gestational age, birthweight, and Apgar score at 5 mins. The 1 min Apgar in those infants with probable infection [4.7 (2.74)] was signi®cantly lower than those infants with no infection, possible infection, contamination, and unclassi®ed infants (p value < 0:05; Mann±Whitney U-test). There were also signi®cantly more subjects with nosocomial infection in the study categories of de®nite and probable infection (chi-square p 0:001).
IL6 and CRP
There were signi®cant differences between study categories 1±6 for IL6 and CRP (see Fig. 1 ). The 18 babies in groups 5 and 6 have not been included in the graphs. The IL6 values in these two groups were not different from those in group 1. There were signi®cant correlation between the initial IL6 and CRP measured after 24 h (Pearson's correlation coef®cient, 0.752). Logistic regression analysis showed that the combination of IL61 and CRP2 gave the best prediction of infection with a goodness of ®t of 97.9 per cent. It is interesting to note that CRP2 alone predicted infection with a goodness of ®t of 95.5 per cent. Positive and negative predictive values and sensitivity and speci®city at previously published cut-off values 7 are shown for CRP and IL6 in Table 2 .
Discussion
The management of suspected neonatal sepsis would be greatly simpli®ed if there were a single reliable marker of infection with results available soon after the onset of signs and symptoms. CRP is not a reliable early marker of infection. 4 Our results suggest that IL6 is useful in the early diagnosis of neonatal infection, especially soon after the onset of signs and symptoms. There is no bene®t in repeating an IL6 after 24 h, as the levels are no longer increased in the infants with infection. This is in agreement with Buck, et al:
8 who showed that IL6 levels returned to baseline after 24 h in the vast majority of infants with sepsis.
Our results are similar to other data in that the best prediction of sepsis was obtained from the combined use of IL6 and CRP, 4;7;8 in particular an initial IL6 determination and a CRP level done after 24 h. The present study showed that the single best predictor of infection was a CRP level done after 24 h. This is in agreement with other studies that show that serial CRP levels provide the most reliable indication of sepsis. 9 These results regarding CRP must be interpreted with some caution as the study was designed to evaluate IL6 in the diagnosis of neonatal infection and not CRP. The CRP was used in the categorizing of infants according to their likelihood of infection and it is therefore to be expected that CRP and category of infection would correlate well.
Most infants evaluated and treated for suspected sepsis are not infected. Less than 10 per cent of the neonates evaluated and treated for sepsis in the present study had de®nite infection. A reliable prediction of the absence of infection would be most useful in the clinical setting as antibiotics could be withheld in more of these infants than is the current practice. The IL6 assay done at the presentation of signs and symptoms in our study showed that there was a negative predictive value of 90.18 per cent at a cut-off value of 20 pg/ml. There was also a good correlation between the early IL6 level and late CRP level in those infants without infection. An early negative IL6 could therefore allow antibiotics to be withheld in a substantial number of infants evaluated for suspected sepsis. This would be very meaningful in practical terms of fewer babies requiring intravenous therapy and high care admission. We suggest that a possible approach to the evaluation of an infant with suspected sepsis would be to do an IL6 at presentation and either serial CRP or a CRP level after 24 h. Antibiotics could be withheld in those infants with an initial IL6 value <20 pg/ml. Our results are not conclusive enough to suggest that these infants could be discharged, but they should be closely observed for a further 24 h prior to discharge and antibiotic therapy started if there is any other suggestion of sepsis. These babies could remain with their mothers and would not require admission to a level 2 neonatal ward. The cost of the IL6 assay could be offset by savings in terms of reduced number of high care neonatal admissions, shorter hospital stay, decreased intravenous antibiotic usage and increased availability of hospital beds.
Several criticisms can be levelled at our study. First, there is no absolute gold standard for the diagnosis of infection in neonates. Contamination may give rise to a positive blood culture, which is particularly problematic, when Staphylococcus epidermidis is present in a blood culture. 10 The classi®cation of infants into categories of the likelihood of infection was based on the clinical judgement of two researchers (M.O.M. and D.E.B.). It is possible that some infants were incorrectly classi®ed and since the infection category was the end point of the study, this might introduce a bias. It was hoped that by having two observers and by using three markers of infection as well as the clinical presentation, errors in the classi®cation were minimized.
The Apgar score was signi®cantly lower in those babies presenting with suspected sepsis during the ®rst 48 h who were classi®ed as having probable infection than that in the other study categories. IL6 is raised in birth asphyxia 11 but we do not feel that asphyxia accounts for the signi®cant differences seen in IL6, since the actual magnitude of difference in Apgar score points on average, although statistically signi®cant, was of less clinical importance. Also, the lowest Apgar scores did not occur in the group with de®nite infection, that is the group with the highest IL6 values.
In conclusion, we suggest that an initial IL6 value less than 20 pg/ml may allow antibiotic therapy to be withheld in a substantial number of babies evaluated for suspected sepsis. These babies should be carefully monitored for at least 24 h and antibiotics started if there is any other suggestion of sepsis. A negative CRP after 24 h would con®rm that the baby was not infected. The bene®t of this approach would be to reduce the number of high care neonatal admissions, decrease the use of intravenous antibiotics and allow earlier discharge with related cost savings. These issues are of paramount importance in developing countries with limited hospital facilities and health resources. It is suggested that IL6 would be a useful addition to the battery of investigations offered as a 24-h service.
